Insulin regulates a wide range of processes including metabolism, development, and aging, but only a handful of its downstream targets are known. We have used 15N metabolic labeling and quantitative proteomics to identify a subset of insulin signaling targets in C. elegans that are differentially expressed in WT,
daf-2 (an insulin receptor) and
daf-16 (a transcription factor negatively regulated by
daf-2) mutants. From the soluble fraction, we have identified 104 proteins that are present in higher or lower levels in
daf-2 than in WT and
daf-16, including known targets SOD-3 and catalases. Gene ontology analysis revealed that the up-regulated proteins in
daf-2 were over-represented in reactive oxygen species metabolism, carbohydrate metabolism, and amino acid biosynthesis, while the down-regulated proteins were enriched in translation and lipid transport. We have confirmed by genetics analysis that some of the candidate insulin signaling components identified in this study play a role in lifespan regulation and/or dauer formation, and one of them is a protein phosphatase. Consistent with our mass spec result that this protein was up-regulated in
daf-2 mutants, the intensity of its GFP fusion protein increased when transgenic worms expressing it were treated with
daf-2 RNAi. In addition, a loss-of-function mutant of this protein exhibited constitutive dauer formation at 27 ºC and had an extended lifespan, both of which were suppressed by a
daf-16 null mutation, suggesting that
daf-16 acts downstream of, and/or in parallel to it. These results suggest that this protein phosphatase is a component of insulin signaling and that a feedback mechanism exists to increases its expression to compensate for decreased insulin signaling in
daf-2. Our results demonstrate the effectiveness of combining quantitative mass spectrometry and C. elegans genetics. This approach can be extended to other studies beyond insulin signaling.